Navigation Links
PAZOO Prepares For First Three National Direct Response Campaigns and Distribution of PAZOO Branded Products
Date:8/23/2012

CEDAR KNOLLS, N.J., Aug. 23, 2012 /PRNewswire/ -- Pazoo, Inc. (OTCBB: PZOO) announces the national roll-out of the first direct response products being marketed under the PAZOO brand name. The initial launch, expected in September 2012, targets adults with a nutritional supplement, stem-cell nutritional product and an anti-aging product. The new PAZOO branded items will be sold at www.pazoo.com, through a digital direct response campaign and is expected to be introduced to brick and mortar retailers soon.

David M. Cunic, CEO of Pazoo, Inc., commented: "The name Pazoo will be synonymous with building total health – both body and mind. PAZOO is, and will be, the leading source of high quality goods and expert information that people can count on to keep them and their pets healthy and happy. This rollout is just another step in this process."

Pazoo, Inc. recently began airing its first national TV ad campaign for pazoo.com. To date, the commercials have resulted in a dramatic increase in consumer visits to pazoo.com, which was launched in early 2012. Approximately 70,000 60-second local spots are scheduled to air through October. Additional marketing support plans for the new PAZOO product line will be announced in a separate communication.

About Pazoo, Inc.:

Pazoo, Inc.'s web site www.pazoo.com provides a warehouse of competitively priced products and a roster of experts in various health and wellness fields who deliver useful information for achieving fuller and richer lives for both humans and their pets. Pazoo.com is a unique, interactive, e-commerce site where consumers can gain insights into health and wellness for themselves and their animals from leading health & wellness and pet industry experts. The company's team of medical, fitness, nutritional and pet professionals seeks to enhance its customers' wellbeing by offering an expanding selection
'/>"/>

SOURCE Pazoo, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Midwest Prepares to Tackle Gnats with an Unlikely Weapon
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Thoratec Schedules First Quarter Conference Call, Webcast
4. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
5. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
8. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
9. Insmed to Host 2012 First Quarter Earnings Conference Call
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 Quietly, sedately, Morocco,s pharmaceutical ... domestic pharmaceutical industry is strong, with a well-developed base ... international standards. One place where the quality ... Africa: Morocco has quietly become the second largest African ... . Indeed, Moroccan pharma companies have been making ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
(Date:7/31/2015)... , July 31, 2015 ... solutions for video, data and cloud computing operators ... a leading pharma giant for Internet of Things ... IoT applications offered on subscription model. ... Pharma giant is striving for business innovations to ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... YORK, Oct. 6, 2011 Reportlinker.com ... report is available in its catalogue: ... Market to 2017 - Patent Expiry ... Impact Dyslipidemia Market Value ...
... NEW YORK, Oct. 6, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0254328/The-Future-of-European-Pharmaceutical-Distribution.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... to reduce internal costs for manufacturers, and ...
Cached Medicine Technology:Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 2Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 3Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 4Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 5Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 6Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 7Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 8Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 9Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 10Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 11Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 12Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 13Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 14Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 15The Future of European Pharmaceutical Distribution 2The Future of European Pharmaceutical Distribution 3The Future of European Pharmaceutical Distribution 4The Future of European Pharmaceutical Distribution 5The Future of European Pharmaceutical Distribution 6The Future of European Pharmaceutical Distribution 7The Future of European Pharmaceutical Distribution 8The Future of European Pharmaceutical Distribution 9
(Date:7/31/2015)... ... ... Girl Scouts of Historic Georgia and Peach State Health Plan are teaming ... Friend First" program. Representatives from Peach State Health Plan presented a $10,000 check for ... our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We are very ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Like nearly ... techniques have also been advanced, upgraded, made more effective and less intrusive and painful. ... Loria Medical Penile Enlargement Center. Dr. Loria currently stands as the only doctor ...
(Date:7/31/2015)... ... July 31, 2015 , ... Florida ... novel catheter that was developed for targeted delivery of fluids to selected sites ... treated at Florida Hospital Tampa with the device that provides direct, local delivery ...
(Date:7/31/2015)... Rochester, N.Y. (PRWEB) , ... July 31, 2015 ... ... Brand, is proud to announce that their latest designer handbag line will be ... recently become an Internet sensation as the first globally recognized model with Down ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to WFLA ... result of heroin use and eventual overdoses. Thricefold deaths have held steady over the ... handle on the Sarasota heroin epidemic, which was spurred by the crackdown of prescription ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3
... Maine, Nov. 12 Nyer Medical Group,Inc. (Nasdaq: ... D.A.W., Inc.,(DAW) has entered into a Pharmacy Service ... its on-site clinic pharmacy for a,two-year period effective ... will receive a dispensing fee for each prescription ...
... ... Hearing, SACRAMENTO, Calif., Nov. 12 , WHAT: ... resorts are being called into question by a diverse and powerful group ... by tragedy. Crowded ski slopes, new ski technologies and limited traffic ...
... (Nov. 12, 2008) It appears that stroke patients ... treatment that dissolves abnormal blood clots and endovascular ... are much more likely to recover and have ... the Zeenat Qureshi Stroke Research Center at the University ...
... with the condition see doctors far more frequently, study ... beneficiaries with heart failure have many more doctor visits ... researchers are reporting. , They based their conclusion on ... overall average age of the beneficiaries was 70.7 years, ...
... The Anthem Blue Cross and Blue,Shield Foundation has ... grant is the largest corporate donation in the Trail,s ... and contributions to,build the Hammonasset Beach Section of Trail ... presentation will be held on November,20, 2008, 2-3 P.M. ...
... 30 September) Unaudited Consolidated Figures, ... 2007 Change ... (%) Turnover 89,760 ... 63,408 35,647 +78% Profit Attributable to ...
Cached Medicine News:Health News:Nyer Medical Group, Inc. Announces Pharmacy Service Agreement with East Boston Neighborhood Health Center 2Health News:Ski Safety and Medical Experts, Victims of Snow Sport Tragedies and Consumers Shed Light on Questionable Safety Practices of California Ski Resorts 2Health News:Dual treatment for stroke leads to improved recovery rates, reduced mortality 2Health News:Heart Failure Accounts for 37% of Medicare Spending 2Health News:Anthem Blue Cross and Blue Shield Foundation Awards $100,000 Grant to Shoreline Greenway Trail 2Health News:Lee's Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008 2Health News:Lee's Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008 3
... A necessary addition to ... the Reichert Trial Frame ... and smooth controls for ... robust design, high-quality materials, ...
... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... Illumination is provided by a cool-running, ... light only what you need to see ... best of all they are maintenance free ... light bulb. Every Phoroptor comes with a ...
Medicine Products: